Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin therapy for streptococcal pharyngitis

C W Derrick, H C Dillon

    American Journal of Diseases of Children (1960)
    |February 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    In utero varicella-zoster infections.

    Southern medical journal·1998
    Same author

    Group B streptococcal C protein-associated antigens: association with neonatal sepsis.

    The Journal of infectious diseases·1991
    Same author

    Risk factors for perinatal group B streptococcal disease after amniotic fluid colonization.

    American journal of obstetrics and gynecology·1990
    Same author

    Radiological cases of the month. Diskitis.

    American journal of diseases of children (1960)·1989
    Same author

    Regionalized perinatal care: the next step.

    Journal of the South Carolina Medical Association (1975)·1989
    Same author

    Seroepidemiology of group B streptococcus type III colonization at delivery.

    The Journal of infectious diseases·1989
    Same journal

    Nonsteroidal anti-inflammatory drugs and gastrointestinal injury in children.

    American journal of diseases of children (1960)·1993
    Same journal

    Picture of the month. Cutaneous leishmaniasis.

    American journal of diseases of children (1960)·1993
    Same journal

    Pathological case of the month. Wells' syndrome.

    American journal of diseases of children (1960)·1993
    Same journal

    Radiological case of the month. Proteus syndrome: benign angiolipomatous tumor with intraspinal extension.

    American journal of diseases of children (1960)·1993
    Same journal

    Applicability of the Greulich and Pyle skeletal age standards to black and white children of today.

    American journal of diseases of children (1960)·1993
    Same journal

    Maltreatment of children born to cocaine-dependent mothers.

    American journal of diseases of children (1960)·1993
    See all related articles

    Eighty-six percent of patients achieved streptococcal eradication with a lower dose of erythromycin estolate. This effective and economical regimen offers a favorable alternative for treating streptococcal infections.

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Microbiology

    Background:

    • Group A Streptococcus (GAS) infections necessitate effective antibiotic treatment.
    • Erythromycin is a commonly prescribed antibiotic for GAS, with varying dosage regimens.
    • Optimizing antibiotic therapy balances efficacy with patient adherence and cost.

    Purpose of the Study:

    • To evaluate the efficacy of a reduced dosage of erythromycin estolate for streptococcal eradication.
    • To compare the effectiveness of this lower dose regimen with standard higher doses.
    • To identify factors contributing to the success of the reduced dosage.

    Main Methods:

    • A ten-day course of erythromycin estolate at 20 mg/kg/day in two divided doses was administered.
    • Patients were assessed for streptococcal eradication on day 14 and day 28 post-therapy.

    Related Experiment Videos

  • Eradication rates were calculated based on microbiological assessments.

    • Main Results:

    • An 86% streptococcal eradication rate was observed in patients assessed.
    • This efficacy was achieved with a significantly lower dose (20 mg/kg/day) compared to typical doses (30-50 mg/kg/day).
    • Factors such as bacterial susceptibility, estolate formulation absorption, and patient compliance likely contributed to success.

    Conclusions:

    • A lower dose of erythromycin estolate (20 mg/kg/day) is effective for streptococcal eradication.
    • This regimen offers a cost-effective and simpler alternative to higher-dose treatments.
    • The findings support the use of optimized, lower-dose erythromycin regimens for GAS infections.